Narrowband ultraviolet B phototherapy for pityriasis lichenoides: A real-life experience

Photodermatol Photoimmunol Photomed. 2023 Sep;39(5):520-526. doi: 10.1111/phpp.12895. Epub 2023 Jun 20.

Abstract

Introduction: Pityriasis lichenoides (PL) is a papulosquamous disease affecting both children and adults, for which narrowband-UVB (NB-UVB) phototherapy is regarded as a commonly used treatment option. The aim of this study was to investigate the efficacy of NB-UVB phototherapy in the management of PL and to compare response rates in pediatric and adult age groups.

Materials and methods: This observational, retrospective study included 20 PL patients (12 pityriasis lichenoides chronica; PLC, 8 pityriasis lichenoides et varioliformis acuta; PLEVA) who failed to respond to other treatment modalities. The data for this study were collected retrospectively from patient follow-up forms in the phototherapy unit.

Results: A complete response (CR) was obtained in all pediatric patients with PL, while 53.8% of adult patients had achieved CR. The mean cumulative dose required to achieve the CR was higher in pediatric patients than adult patients with PL (p < .05). The CR was achieved in 6 (75%) of 8 PLEVA patients, while 8 (66.7%) of 12 PLC patients had reached to CR. The mean number of exposures for patients with PLC to achieve a CR was higher than patients with PLEVA (p < .05). Erythema was the most common adverse effect during phototherapy particularly in 5 (35.7%) of the patients with PL who had achieved CR.

Conclusions: NB-UVB is an effective and well-tolerated treatment option for PL especially in diffuse types. A higher response can be obtained in children with higher cumulative dose. Patients with PLC may require more exposures for CR than patients with PLEVA.

Keywords: Pityriasis lichenoides; adult; children; narrow-band UVB; phototherapy.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Child
  • Humans
  • Phototherapy
  • Pityriasis Lichenoides* / radiotherapy
  • Retrospective Studies
  • Ultraviolet Rays
  • Ultraviolet Therapy* / adverse effects